This receptor was also not modulated by typical opiate agonists, which involve morphine, fentanyl, buprenorphine, or antagonists like naloxone. In an exceptionally rat solution, it had been identified that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’s inhibitory action, triggering an Overall Enhance in opiate receptor e